Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
The Newable EIS Scale-up Fund invests in 7-10 companies per year, across various sectors within future tech, including medical technology, hardware & robotics, AI & automation, and space technology. It targets returns of 3x, and sources deals through a wide network of business angels, universities, incubators and accelerators.
Newable Ventures is a division of the Newable Group. Since 2015, Newable Ventures has invested £7.6 million into investee companies, £6 of this through the Newable Ventures EIS Scale-up. The wider Newable Group is a key part of Newable Ventures'' investment strategy, and represents a source of support and opportunity to help investee companies scale.
How does SyndicateRoom''s Access EIS Fund compare?
By comparison, SyndicateRoom''s Access EIS fund builds investors a large portfolio of 50+ companies across all sectors, co-investing with experienced angel investors who have an average IRR of 42%. Our model is based on our proprietary analysis of the UK startup market, which showed that on average, the market grows by 28% each year. With large portfolios, and a large network of angels providing access to the best deals, earlier, we aim to replicate that annual growth for our investors while mitigating risk. This data-driven approach aims to work around the limitations of a single fund manager attempting to pick winners.
Our minimum investment is £5,000.
| | |
|----------------------------------|:----------------------:|
| **Fund Manager:** | SyndicateRoom |
| **Tax Efficiency:** | EIS |
| **Sector Focus:** | Sector Agnostic |
| **Stage Focus:** | Early-stage |
| **Target Portfolio Size:** | 50+ companies |
| **Minimum Subscription:** | £5,000 |
| **Closing Date:** | Evergreen |
| **Website:** | [Learn more about the Access EIS Fund](/eis/invest) |
Please note: SyndicateRoom is not affiliated with Newable EIS Scale-up Fund. This page is for informational purposes only, and is the result of research conducted by SyndicateRoom. Whilst every effort has been taken to ensure accuracy at the time of publication this cannot be guaranteed and information is liable to change. Information displayed is neither a recommendation to invest or not, nor advice. With investments, your capital is at risk. SyndicateRoom is not responsible for the content of any external websites linked to from this page.
Are you the fund manager? Email [tom@syndicateroom.com](mailto:tom@syndicateroom.com) with any comments or amends.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.
Syndicate Room Ltd is registered in England and Wales. Number 07697935. Registered office: Wellington House, East Road, Cambridge, Cambridgeshire, CB1 1BH, United Kingdom
Please provide your email and/or phone number and we'll get back to you as soon as possible.
